Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donafenib”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)Study completedNCT05262959
What this trial is testing

A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC

Who this might be right for
Donafenib
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Early research (Phase 1)UnknownNCT04472858
What this trial is testing

CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06512467
What this trial is testing

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Study completedNCT02645981
What this trial is testing

Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
HCC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 668
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Testing effectiveness (Phase 2)UnknownNCT04979663
What this trial is testing

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Who this might be right for
Biliary Tract Carcinoma
Fudan University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)UnknownNCT04612712
What this trial is testing

Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 42
Not applicableUnknownNCT05205629
What this trial is testing

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaDonafenib
Shanghai Zhongshan Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT06498622
What this trial is testing

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Who this might be right for
Hepatocellular Carcinoma
Anhui Provincial Hospital 45
Early research (Phase 1)Study completedNCT04816123
What this trial is testing

The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man

Who this might be right for
Healthy Male Adult
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 6
Testing effectiveness (Phase 2)Looking for participantsNCT06685289
What this trial is testing

Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk

Who this might be right for
Biliary Malignant Tumors
The First Affiliated Hospital with Nanjing Medical University 70
Testing effectiveness (Phase 2)Study completedNCT02489916
What this trial is testing

Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 47
Testing effectiveness (Phase 2)Study completedNCT05162352
What this trial is testing

Donafenib Plus Sintilimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)UnknownNCT05138159
What this trial is testing

Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen

Who this might be right for
Metastatic Pancreatic Cancer
Fudan University 10
Testing effectiveness (Phase 2)Study completedNCT02870569
What this trial is testing

Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 48
Early research (Phase 1)Ended earlyNCT04402723
What this trial is testing

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 8
Testing effectiveness (Phase 2)UnknownNCT05576909
What this trial is testing

Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Load More Results